Clinical Archives - Page 30 of 180 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Clinical

BRCA testing – making treatment decisions today and planning for the future

BRCA testing – making treatment decisions today and planning for the future

Scientists discover source for counteracting drug resistance in tumour cells

Scientists discover source for counteracting drug resistance in tumour cells

Sponsored – The importance of vascular access device selection: case study

Cannabis oil improves symptoms of Crohn’s despite no effect on gut inflammation

Cannabis oil improves symptoms of Crohn’s despite no effect on gut inflammation

Bowel cancer rates increasing across Europe

Bowel cancer rates increasing across Europe

European Commission grants marketing authorisation for Kigabeq

European Commission grants marketing authorisation for Kigabeq

Ustekinumab shows sustained efficacy in improving remission rates in Crohn’s disease over three years

Ustekinumab shows sustained efficacy in improving remission rates in Crohn’s disease over three years

Repatha® (evolocumab) selected as a Rapid Uptake Product

Repatha® (evolocumab) selected as a Rapid Uptake Product

Implanted cardiac defibrillator (ICD) can put a stop to underlying cardiac arrhythmia

Implanted cardiac defibrillator (ICD) can put a stop to underlying cardiac arrhythmia

Patients with HPV-positive oropharynx cancer should receive chemoradiation

Patients with HPV-positive oropharynx cancer should receive chemoradiation

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Erlotinib improves progression-free survival in early mutated non-small cell lung cancer

Erlotinib improves progression-free survival in early mutated non-small cell lung cancer

Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer

Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer

Drugs for treating breast cancer in women are effective and well tolerated in men

Drugs for treating breast cancer in women are effective and well tolerated in men